Various treatment formats, either in a live-in facility or through regular visits to a clinic, are designed for ongoing support, to help maintain recovery, and to prevent relapse.
For the first time, the International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA) and the International Consortium of Universities for Drug Demand Reduction (ICUDDR) will co-host a thematic meeting in Africa focused on the future of Screening, Brief Intervention, and Referral to Treatment (SBIRT) across the continent, in collaborat
On behalf of the International Society of Addiction Medicine, the Netherlands Society of Addiction Medicine and NOVA Postgraduate Training Institute for Addiction Medicine, we welcome you to the XXVIII ISAM Congress in Rotterdam, the Netherlands.
This interactive training covers the 2025 updates to the NAADAC Code of Ethics and provides practical tools for ethical decision-making in behavioral health. Using real-world case studies, participants will explore boundary management, dual relationships, ethical self-disclosure, and strategies to prevent burnout and countertransference.
Substance use disorders (SUDs) are common, affecting at least 1 of 3 adult Americans at some point in their lives. One of the many characteristics of SUDs that makes them unique is that the nature of the addictive process is such that denial, minimization, and lack of insight are natural components of the development of the disorder.
The 17th European Opiate Addiction Treatment Association (EUROPAD) conference will be held in Bucharest, Romania on May 29-31, 2026.
Symposia have a central theme around which the EUROPAD2026BUCHAREST scientific committee has identified topics. The structure of the symposium will take the shape of 3 presentations with 30 minutes per presentation. The length of each symposium is 90 minutes.
Join us for the 2026 Annual Meeting, May 16-20 in San Francisco for 4.5 days of engaging programming for the future of psychiatry! Early rates are now available for in-person registration.
For 15 years, the Rx and Illicit Drug Summit has been a leading force in the fight against the opioid and addiction crisis. It remains the most influential gathering of stakeholders, where groundbreaking ideas are exchanged, strategies are forged, and action takes root. Our work is not done.
